Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 149.00
-3.44 (-2.26%)
At close: Jan 22, 2026
Beijing Hotgen Biotech Revenue
Beijing Hotgen Biotech had revenue of 105.80M CNY in the quarter ending September 30, 2025, a decrease of -22.98%. This brings the company's revenue in the last twelve months to 434.45M, down -17.58% year-over-year. In the year 2024, Beijing Hotgen Biotech had annual revenue of 510.90M, down -6.74%.
Revenue (ttm)
434.45M
Revenue Growth
-17.58%
P/S Ratio
30.47
Revenue / Employee
481.11K
Employees
903
Market Cap
13.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 510.90M | -36.94M | -6.74% |
| Dec 31, 2023 | 547.84M | -3.01B | -84.60% |
| Dec 31, 2022 | 3.56B | -1.81B | -33.76% |
| Dec 31, 2021 | 5.37B | 4.86B | 945.54% |
| Dec 31, 2020 | 513.53M | 303.12M | 144.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition